FACT - antibacterial drug from the group of fluoroquinolones.
FACT - antibacterial
drug that has a broad spectrum bactericidal action, inhibits gram-positive and gram-negative organisms.
Active substance formulation gemifloxacin which gives subsidiary synthesis of a DNA molecule, the ability to restore data of DNA and RNA synthesis - these processes are essential for the growth of bacteria.
Facts available in tablets.
If the drug you can not find in your local pharmacy, you should pay attention to Factiva counterparts with the same active ingredient: gemifloxacin, Gemifloksatsinamezilat, Gemiks.
The facts of the instructions is used for such infectious diseases: acute sinusitis, community-acquired pneumonia, an exacerbation of chronic bronchitis.
Instructions Factiva - method of application
Tablets Factiva ingested, regardless of mealtime. They should not be chewed, can be washed down with water.
The usual dose is 320 mg per day.
For patients who are on hemodialysis or continuous peritoneal dialysis, the dose must be corrected, and it is the instructions Factiva is 160 mg per day.
In the case of liver failure and elderly patients dose adjustment is required.
Side effects Factiva
cause various allergic reactions, disorders of the digestive system, such as nausea or diarrhea, disorders in the nervous system, disturbances of taste and smell. Upon detection of abnormalities in the central nervous system to stop taking Factiva.
There are also reviews of Factiva, cause trouble on the urinary system, blood system, as well as improving laboratory parameters - increase sodium levels, bilirubin, platelet count in the blood.
Facts should not be administered to patients with known hypersensitivity to fluoroquinolones, in particular, to gemifloxacin.
Facts and its analogs also contraindicated in elongated QT-interval on the ECG.
You can not assign the drug to children under 18 years of age and women during pregnancy and breastfeeding.
With extreme caution should be taken Facts patients at risk for arrhythmias receiving steroids, and those who have an increased risk of damage to the tendon.